Java 26, due in March with structured concurrency, lazy constants, AOT object caching, and primitive types in patterns, instanceof, and switch, has entered a second rampdown phase for bug fixes. Java ...

Add Yahoo as a preferred source to see more of our stories on Google. According to Mike’s ending explanation, Eleven is actually still alive in Stranger Things 5: The Finale. Mike shares that he ...

SPOILER ALERT: This post contains major plot details from Volume 2 of Stranger Things Season 5 – Episodes 505-507. Three more episodes of Stranger Things Season 5 have arrived, leaving just the ...

Netflix’s latest Korean blockbuster The Great Flood has surged to the top of the platform’s global charts for nonglobal films, but audiences are divided over its cryptic ending and philosophical twist ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Staking is one of the most common ways crypto holders earn rewards simply by holding and committing their tokens to a blockchain network. Often described as “earning passive income in crypto,” staking ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Traditional caching fails to stop "thundering ...

The second movie adaptation offers a subtle but meaningful nod to 'The Wizard of Oz' — and a closing scene with Ariana Grande and Cynthia Erivo that longtime fans of the musical will appreciate. By ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...

Investors in Recursion (NASDAQ: RXRX) seemed only mildly fazed by Wednesday’s series of company announcements. The artificial intelligence (AI)-based drug developer’s stock barely moved on Wednesday, ...